Literature DB >> 20846127

Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population.

Abdulbari Bener1, Abdul-Ghani Mohammad, Asia N Ismail, Mahmoud Zirie, Waleed K Abdullatef, Abdulla O A A Al-Hamaq.   

Abstract

The objective of the study was to examine the differences in gender and age prevalences of metabolic syndrome (MetS) among adult Qatari population according to the revised criteria of NCEP ATP III and IDF, assess which component contributed to the higher prevalence of the MetS and identify the characteristics of the subjects with MetS. The study was designed as a cross-sectional study. The survey was carried out in urban and semi-urban primary health care centers. The survey was conducted in the period from January 2007 to July 2008 among Qatari nationals above 20 years of age. Of the 1536 subjects who were approached to participate in the study, 1222 (79.6%) gave their consent. Face to face interviews were conducted using a structured questionnaire followed by laboratory tests. MetS was defined using the National Cholesterol Education Program - Third Adult Treatment Panel (ATP III) as well as the International Diabetes Federation (IDF). The overall prevalence of MetS in studied subjects was 26.7% and 33.9% according to ATPIII and IDF (p<0.001) criteria respectively. The prevalence of MetS by both definitions peaked in the 30-39 years age group among males, and the 40-49 years age group among females. The greatest number of males with MetS were university educated; while the greatest number of females with MetS were either illiterate or had a primary school education. The prevalence of MetS was higher among females. Among the components of MetS, the prevalence of central obesity was significantly higher in studied subjects. The overall prevalence of MetS and its components according to IDF criteria was higher in studied subjects than the estimates given by the ATPIII criteria. Overall, the prevalence of the metabolic syndrome in the State of Qatar is about 10-15% higher than in most developed countries, with generally higher prevalence rates for women. Preventive strategies will require identifying socio-demographic factors and addressing modifiable risk behaviours, including lack of physical activity, and dietary intake.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846127      PMCID: PMC5504497          DOI: 10.17305/bjbms.2010.2687

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  28 in total

Review 1.  Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review.

Authors:  R M Mabry; M M Reeves; E G Eakin; N Owen
Journal:  Diabet Med       Date:  2010-05       Impact factor: 4.359

Review 2.  Ectopic fat accumulation and metabolic syndrome.

Authors:  Neda Rasouli; Behzad Molavi; Steven C Elbein; Philip A Kern
Journal:  Diabetes Obes Metab       Date:  2007-01       Impact factor: 6.577

3.  Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.

Authors:  S Goya Wannamethee; A Gerald Shaper; Lucy Lennon; Richard W Morris
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

Review 4.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey.

Authors:  Mahdi Malik; Sawsan Abdel Razig
Journal:  Metab Syndr Relat Disord       Date:  2008-09       Impact factor: 1.894

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.

Authors:  Abdulbari Bener; Mahmoud Zirie; Manal Musallam; Yousef S Khader; Abdulla O A A Al-Hamaq
Journal:  Metab Syndr Relat Disord       Date:  2009-06       Impact factor: 1.894

9.  Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study.

Authors:  P Henneman; Y S Aulchenko; R R Frants; K W van Dijk; B A Oostra; C M van Duijn
Journal:  J Med Genet       Date:  2008-06-11       Impact factor: 6.318

10.  Gender, socio-economic status and metabolic syndrome in middle-aged and old adults.

Authors:  Ana C Santos; Shah Ebrahim; Henrique Barros
Journal:  BMC Public Health       Date:  2008-02-18       Impact factor: 3.295

View more
  12 in total

1.  Metabolic Syndrome and Body Composition Among People Aged 50 Years and Over: Results from The Neyshabur Longitudinal Study on Ageing (NeLSA).

Authors:  Mohsen Azimi-Nezhad; Nayyereh Aminisani; Ahmad Ghasemi; Azam Rezaei Farimani; Fatemeh Khorashadizadeh; Seyed Reza Mirhafez; Martin Hyde; Seyed Morteza Shamshirgaran
Journal:  Indian J Clin Biochem       Date:  2021-11-15

2.  High-normal urinary albumin-to-creatinine ratio is independently associated with metabolic syndrome in Chinese patients with type 2 diabetes mellitus: A cross-sectional community-based study.

Authors:  Mei-Fang Li; Qi-Ming Feng; Lian-Xi Li; Yin-Fang Tu; Rong Zhang; Xue-Hong Dong; Jun-Xi Lu; Yu-Qian Bao; Wei-Ping Jia; Ren-Ming Hu
Journal:  J Diabetes Investig       Date:  2014-12-13       Impact factor: 4.232

3.  Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio.

Authors:  Abdulbari Bener; Mohammad T Yousafzai; Sarah Darwish; Abdulla O A A Al-Hamaq; Eman A Nasralla; Mohammad Abdul-Ghani
Journal:  J Obes       Date:  2013-08-13

4.  Incidence of metabolic syndrome and relative importance of five components as a predictor of metabolic syndrome: 5-year follow-up study in Korea.

Authors:  Jun Hyun Hwang; Sin Kam; Ji-yeon Shin; Jong-Yeon Kim; Kyung-Eun Lee; Gi-Hong Kwon; Byung-Yeol Chun; Shung Chull Chae; Dong Heon Yang; Hun Sik Park; Tae-Yoon Hwang
Journal:  J Korean Med Sci       Date:  2013-11-26       Impact factor: 2.153

5.  Comparing the Ability of Anthropometric Indicators in Identifying Metabolic Syndrome in HIV Patients.

Authors:  Rebeca Antunes Beraldo; Gabriela Cristina Meliscki; Bruna Ramos Silva; Anderson Marliere Navarro; Valdes Roberto Bollela; André Schmidt; Maria Cristina Foss-Freitas
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

6.  Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis.

Authors:  Paul B Nolan; Graeme Carrick-Ranson; James W Stinear; Stacey A Reading; Lance C Dalleck
Journal:  Prev Med Rep       Date:  2017-07-19

7.  Serum E-selectin concentration is associated with risk of metabolic syndrome in females.

Authors:  Chien-Hsing Lee; Feng-Chih Kuo; Wen-Hao Tang; Chieh-Hua Lu; Sheng-Chiang Su; Jhih-Syuan Liu; Chang-Hsun Hsieh; Yi-Jen Hung; Fu-Huang Lin
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

8.  Association of Age and Sex with Metabolic Syndrome in Taiwanese Adults.

Authors:  Pang-Li Liu; Ming-Yi Hsu; Chao-Chin Hu; Disline Manli Tantoh; Wen-Yu Lu; Oswald Ndi Nfor; Yung-Po Liaw
Journal:  Int J Gen Med       Date:  2021-04-20

9.  The potential impact of family history of metabolic syndrome and risk of type 2 diabetes mellitus: In a highly endogamous population.

Authors:  Abdulbari Bener; Sarah Darwish; Abdulla O A Al-Hamaq; Mohammad T Yousafzai; Eman A Nasralla
Journal:  Indian J Endocrinol Metab       Date:  2014-03

10.  The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study.

Authors:  Samer Hammoudeh; Suhaila Ghuloum; Ziyad Mahfoud; Arij Yehya; Abdulmoneim Abdulhakam; Azza Al-Mujalli; Mahmoud Al-Zirie; Mohamed Osman Abdel Rahman; Angela Godwin; Noura Younes; Yahya Hani; Dennis Mook-Kanamori; Marjonneke Mook-Kanamori; Reem El Sherbiny; Hassen Al-Amin
Journal:  BMC Psychiatry       Date:  2018-03-27       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.